Content of long-term culture-initiating cells, clonogenic progenitors and CD34+ cells in apheresis harvests of normal donors for allogeneic transplantation, and in patients with acute myeloid leukaemia or multiple myeloma

被引:4
|
作者
Kasper, C
Ryder, WDJ
Dürig, J
Nagesh, K
Scarffe, JH
Beelen, DW
Schaefer, UW
Chang, J
Testa, NG
机构
[1] Christie Hosp, Canc Res Campaign, Dept Expt Haematol, Manchester, Lancs, England
[2] Christie Hosp, Canc Res Campaign, Dept Med Oncol, Manchester, Lancs, England
[3] Christie Hosp, Canc Res Campaign, Dept Med Stat, Manchester, Lancs, England
[4] Univ Hosp Essen, Dept Bone Marrow Transplantat, Essen, Germany
关键词
long-term culture-initiating cells; peripheral blood progenitor cells; CD34(+) cells; multiple myeloma; acute myeloid leukaemia;
D O I
10.1046/j.1365-2141.1999.01152.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Using a limiting dilution assay the frequency of lone-term culture-initiating cells (LTC-IC) in the apheresis products following mobilization by granulocyte-colony stimulating factor (G-CSF) with or without chemotherapy from 14 normal donors (ND) for allogeneic bone marrow transplantation, 16 patients with multiple myeloma (MM) and 15 patients with acute myeloid leukaemia (AML), where the aphereses were intended for autologous transplantation. were compared. The estimated median incidences of LTC-IC in the first apheresis products from NU, MM and AML were 1/3289, 1/1775 and 1/13075 mononuclear cells (MNC) respectively. The patients with AML had a significantly lower incidence compared with the other two groups (P < 0.0001). There was a positive correlation between the incidence of LTC-IC and the number of CD34(+) cells, the number of GM-CFC. and the number of BFU-E. The positive association with GM-CFC or BFU-E was weaker. In these experiments the percentage of CD34(+) cells was the best predictor for the frequency of LTC-TC in the peripheral blood progenitor cells (PBPC). In eight cases of MM the LTC-IC assay was performed for both the first and second harvest. All cases had a lower LTC-IC frequency in the second harvest compared with the first, an average of 23% (13-42%,. 95% confidence interval) and this reduction was statistically significant (P < 0.001): CD34(+) cells were also lower (P < 0.001).
引用
收藏
页码:374 / 381
页数:8
相关论文
共 50 条
  • [31] Blood-derived macrophage layers in the presence of hydrocortisone support myeloid progenitors in long-term cultures of CD34+ cord blood and bone marrow cells
    J. Clausen
    M. Stockschläder
    N. Fehse
    H. T. Hassan
    C. Gabl
    A. R. Zander
    Annals of Hematology, 2000, 79 : 59 - 65
  • [32] Blood-derived macrophage layers in the presence of hydrocortisone support myeloid progenitors in long-term cultures of CD34+ cord blood and bone marrow cells
    Clausen, J
    Stockschläder, M
    Fehse, N
    Hassan, HT
    Gabl, C
    Zander, AR
    ANNALS OF HEMATOLOGY, 2000, 79 (02) : 59 - 65
  • [33] Lineage commitment of CD34+ cells from steady-state bone marrow (BM) and peripheral blood stem cells (PBSC) harvests: A comparison between healthy donors and multiple myeloma (MM) patients
    Papadhimitriou, SI
    Spanakos, G
    Baxevanis, CN
    Filis, I
    Tsaftaridis, P
    Stamatelou, M
    Papamichail, M
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 423 - 423
  • [34] Long-term follow up of sequential mobilisation and autologous transplantation with CD34-selected cells in multiple myeloma: a multimodality approach
    Horvath, N
    Hahn, U
    Joshua, D
    Dyson, P
    Gibson, J
    Stevens, J
    Rawling, T
    Barrow, L
    Brown, R
    Stephens, S
    Gower, G
    Norman, J
    Mills, B
    To, LB
    INTERNAL MEDICINE JOURNAL, 2004, 34 (04) : 167 - 175
  • [35] Downregulation of MEIS1 impairs long-term expansion of CD34+ NPM1-mutated acute myeloid leukemia cells
    C M Woolthuis
    L Han
    R N Verkaik-Schakel
    D van Gosliga
    P M Kluin
    E Vellenga
    J J Schuringa
    G Huls
    Leukemia, 2012, 26 : 848 - 853
  • [36] Downregulation of MEIS1 impairs long-term expansion of CD34+ NPM1-mutated acute myeloid leukemia cells
    Woolthuis, C. M.
    Han, L.
    Verkaik-Schakel, R. N.
    van Gosliga, D.
    Kluin, P. M.
    Vellenga, E.
    Schuringa, J. J.
    Huls, G.
    LEUKEMIA, 2012, 26 (04) : 848 - 853
  • [37] Platelet-derived growth factor promotes ex vivo expansion of CD34+ cells from human cord blood and enhances long-term culture-initiating cells, non-obese diabetic/severe combined immunodeficient repopulating cells and formation of adherent cells
    Su, RJ
    Zhang, XB
    Li, K
    Yang, M
    Li, CK
    Fok, TF
    James, AE
    Pong, H
    Yuen, PMP
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (03) : 735 - 746
  • [38] Demonstration of long-term engraftment of donor CD34+ HLA-DR. bone marrow cells after allogeneic peripheral blood transplantation.
    Briones, J
    Urbano-Ispizua, A
    Orfao, A
    Marin, P
    Sierra, J
    Rovira, M
    Carreras, E
    Rozman, C
    Montserrat, E
    BONE MARROW TRANSPLANTATION, 1998, 21 : S104 - S104
  • [39] Distinct requirements for optimal growth and in vitro expansion of human CD34+CD38- bone marrow long-term culture-initiating cells (LTC-IC), extended LTC-IC, and murine in vivo long-term reconstituting stem cells
    Ramsfjell, V
    Bryder, D
    Björgvinsdóttir, H
    Kornfält, S
    Nilsson, L
    Borge, OJ
    Jacobsen, SEW
    BLOOD, 1999, 94 (12) : 4093 - 4102
  • [40] Correlation between subsets of CD34+cells and early and long-term engraftment after autologous peripheral stem cell transplantation in acute myeloblastic leukaemia patients
    Pastore, D
    Mestice, A
    Carluccio, P
    Liso, A
    Ciuffreda, L
    Pietrantuono, G
    Sibilla, S
    Giannoccaro, M
    Liso, V
    Specchia, G
    BONE MARROW TRANSPLANTATION, 2005, 35 : S221 - S222